2-(乙酰氧基)-1-(3-硝基苯基)-乙酮 | 90945-65-6

• 分子结构分类: 有机化合物 - 有机氧化合物
• 中文名称: 2-(乙酰氧基)-1-(3-硝基苯基)-乙酮
• 英文名称: 2-(3-nitrophenyl)-2-oxoethyl acetate
• 英文别名: [2-(3-nitrophenyl)-2-oxoethyl] acetate
• CAS: 90945-65-6
• 化学式: C₁₀H₉NO₅
• mdl: MFCD16617522
• 分子量: 223.185
• InChiKey: FCIKBZZNPRLWPD-UHFFFAOYSA-N

物化性质

• 沸点：
  318.5±17.0 °C(Predicted)
• 密度：
  1.318±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.3
• 重原子数：
  16
• 可旋转键数：
  4
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.2
• 拓扑面积：
  89.2
• 氢给体数：
  0
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  2-(乙酰氧基)-1-(3-硝基苯基)-乙酮 在 硫酸 、 水 作用下， 生成 2-羟基-1-(3-硝基苯基)-1-乙酮
  参考文献：
  名称：

  Evans; Brooks, Journal of the American Chemical Society, 1908, vol. 30, p. 406

  摘要：

  DOI：
• 作为产物：
  描述：

  间硝基苯乙酮 在 氯仿 、 溴 作用下， 生成 2-(乙酰氧基)-1-(3-硝基苯基)-乙酮
  参考文献：
  名称：

  Evans; Brooks, Journal of the American Chemical Society, 1908, vol. 30, p. 406

  摘要：

  DOI：

文献信息

• Decarboxylative Oxyacyloxylation of Propiolic Acids: Construction of Alkynyl-Containing α-Acyloxy Ketones
  作者：Xin Chen、Yangchun Xin、Zhi-Wei Zhao、Yu-Jian Hou、Xiang-Xiang Wang、Wen-Jin Xia、Ya-Min Li

  DOI：10.1021/acs.joc.1c00669

  日期：2021.6.18

  Novel decarboxylative oxyacyloxylation of propiolic acids has been developed. This reaction provides an efficient access to alkynyl-containing α-acyloxy ketones from readily available starting materials and exhibits significant functional group tolerance. Furthermore, oxyacyloxylation of terminal alkynes and aliphatic propiolic acids was also developed. A possible reaction mechanism is proposed based

  已开发出丙炔酸的新型脱羧氧基酰氧基化。该反应提供了从容易获得的起始材料中有效获取含炔基的 α-酰氧基酮的途径，并表现出显着的官能团耐受性。此外，还开发了末端炔烃和脂肪族丙炔酸的氧酰氧基化。基于机理研究提出了一种可能的反应机理。
• An Efficient Method for the α-Acetoxylation of Ketones
  作者：Guosheng Huang、Jinmei Sheng、Xiaolong Li、Mingfang Tang、Botao Gao

  DOI：10.1055/s-2007-965984

  日期：2007.4

  alpha-Acetoxylation of ketones catalyzed by iodobenzene using 30% aqueous hydrogen peroxide and acetic anhydride as the oxidant is an effective and economical method for the preparation of alpha-acetoxy ketones. The reaction gave the products in good yields without the addition of acetic acid and water.

  碘苯催化酮的α-乙酰氧基化反应，使用30%的过氧化氢水溶液和乙酸酐作为氧化剂，是制备α-乙酰氧基酮的一种有效且经济的方法。该反应在不添加乙酸和水的情况下以良好的收率得到产物。
• [EN] ARYL-PHENYL-SULFONAMIDE-PHENYLENE COMPOUNDS AND THEIR USE<br/>[FR] COMPOSÉS ARYL-PHÉNYL-SULFONAMINO-PHÉNYLÈNE ET LEURS UTILISATIONS
  申请人：PIMCO 2664 LTD

  公开号：WO2010032010A1

  公开（公告）日：2010-03-25

  The present invention pertains generally to the field of therapeutic compounds, and more specifically to certain aryl-phenyl-sulfonamido-phenylene compounds of the following formula (I) (collectively referred to herein as "APSAP compounds"). The present invention also pertains to pharmaceutical compositions comprising such compounds, and the use of such compounds and compositions, both in vitro and in vivo, in treatment, for example, of inflammation and/or joint destruction and/or bone loss; of disorders mediated by excessive and/or inappropriate and/or prolonged activation of the immune system; of inflammatory and autoimmune disorders, for example, rheumatoid arthritis, psoriasis, psoriatic arthritis, chronic obstructive pulmonary disease (COPD), atherosclerosis, inflammatory bowel disease, ankylosing spondylitis, and the like; of disorders associated with bone loss, such as bone loss associated with excessive osteoclast activity in rheumatoid arthritis, osteoporosis, cancer-associated bone disease, Paget's disease and the like, etc.; and of cancer, such as a haematological malignancy, a solid tumour, etc.

  本发明通常涉及治疗化合物领域，更具体地涉及以下式(I)的某些芳基苯磺酰胺基苯基化合物（以下统称为“APSAP化合物”）。本发明还涉及包含这些化合物的药物组合物，以及这些化合物和组合物在体内外的使用，例如用于治疗炎症和/或关节破坏和/或骨质流失；过度和/或不适当和/或持续激活免疫系统的疾病；炎症性和自身免疫性疾病，例如类风湿关节炎、牛皮癣、银屑病性关节炎、慢性阻塞性肺病（COPD）、动脉粥样硬化、炎症性肠病、强直性脊柱炎等；与骨质流失相关的疾病，例如类风湿性关节炎中与过度破骨细胞活性相关的骨质流失、骨质疏松症、癌症相关骨病、帕吉特病等；以及癌症，如血液系统恶性肿瘤、实体肿瘤等。
• Aryl-Phenyl-Sulfonamide-Phenylene Compounds and Their Use
  申请人：Greig Iain Robert

  公开号：US20110190302A1

  公开（公告）日：2011-08-04

  The present invention pertains generally to the field of therapeutic compounds, and more specifically to certain aryl-phenyl-sulfonamido-phenylene compounds of the following formula (I) (collectively referred to herein as “APSAP compounds”). The present invention also pertains to pharmaceutical compositions comprising such compounds, and the use of such compounds and compositions, both in vitro and in vivo, in treatment, for example, of inflammation and/or joint destruction and/or bone loss; of disorders mediated by excessive and/or inappropriate and/or prolonged activation of the immune system; of inflammatory and autoimmune disorders, for example, rheumatoid arthritis, psoriasis, psoriatic arthritis, chronic obstructive pulmonary disease (COPD), atherosclerosis, inflammatory bowel disease, ankylosing spondylitis, and the like; of disorders associated with bone loss, such as bone loss associated with excessive osteoclast activity in rheumatoid arthritis, osteoporosis, cancer-associated bone disease, Paget's disease and the like, etc.; and of cancer, such as a haematological malignancy, a solid tumour, etc.

  本发明涉及治疗化合物领域，更具体地涉及以下公式（I）的某些芳基-苯基-磺酰胺基-苯基化合物（以下统称为“APSAP化合物”）。本发明还涉及包含这些化合物的制药组合物，以及这些化合物和组合物的使用，无论是在体外还是体内，用于治疗炎症和/或关节破坏和/或骨质流失；治疗由免疫系统过度和/或不适当和/或持续激活引起的疾病；治疗炎症和自身免疫性疾病，例如类风湿性关节炎、牛皮癣、银屑病性关节炎、慢性阻塞性肺疾病（COPD）、动脉粥样硬化、炎性肠病、强直性脊柱炎等；治疗与骨质流失有关的疾病，例如类风湿关节炎中过度破骨细胞活动引起的骨质流失、骨质疏松症、癌症相关骨病、帕吉特病等；以及治疗癌症，例如血液系统恶性肿瘤、实体瘤等。
• Aryl-phenyl-sulfonamide-phenylene compounds and their use
  申请人：PIMCO 2664 Limited

  公开号：US08207167B2

  公开（公告）日：2012-06-26

  The present invention pertains generally to the field of therapeutic compounds, and more specifically to certain aryl-phenyl-sulfonamido-phenylene compounds of the following formula (I) (collectively referred to herein as “APSAP compounds”). The present invention also pertains to pharmaceutical compositions comprising such compounds, and the use of such compounds and compositions, both in vitro and in vivo, in treatment, for example, of inflammation and/or joint destruction and/or bone loss; of disorders mediated by excessive and/or inappropriate and/or prolonged activation of the immune system; of inflammatory and autoimmune disorders, for example, rheumatoid arthritis, psoriasis, psoriatic arthritis, chronic obstructive pulmonary disease (COPD), atherosclerosis, inflammatory bowel disease, ankylosing spondylitis, and the like; of disorders associated with bone loss, such as bone loss associated with excessive osteoclast activity in rheumatoid arthritis, osteoporosis, cancer-associated bone disease, Paget's disease and the like, etc.; and of cancer, such as a haematological malignancy, a solid tumor, etc.

  本发明涉及治疗化合物领域，更具体地涉及以下公式（I）的某些芳基-苯基-磺酰胺基-苯基化合物（统称为“APSAP化合物”）。本发明还涉及包含这种化合物的制药组合物，以及这种化合物和组合物的使用，无论是体外还是体内，用于治疗炎症和/或关节破坏和/或骨质流失等疾病；过度和/或不适当和/或长时间激活免疫系统介导的疾病；炎症性和自身免疫性疾病，例如类风湿性关节炎、银屑病、银屑病性关节炎、慢性阻塞性肺疾病（COPD）、动脉硬化、炎症性肠病、强直性脊柱炎等；与骨质流失有关的疾病，例如类风湿性关节炎中过度破骨细胞活性、骨质疏松症、与癌症相关的骨病、帕吉特病等；以及癌症，例如血液系统恶性肿瘤、实体肿瘤等。